Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Dr. Hazel Jones, CEO, Enhanc3D Genomics	Dr. Dan Turner, CSO, Enhanc3D Genomics
    14 January 2025

    Enhanc3D Genomics launches suite of 3D multi-omics solutions to accelerate drug development

    Solutions driven by proprietary, integrated multi-omics platform to support data-driven, faster and more precise drug discovery and development, to be introduced during JPM Week Provides customers with access to Enhanced’s 3D genomics technology and 3D Multi-Omic Platform, to trans...

    Pheno Therapeutics
    14 January 2025

    Pheno Therapeutics granted clinical trial authorisation for lead multiple sclerosis therapeutic candidate PTD802

    UK MHRA grants CTA for first-in-human trial of a selective GPR17 antagonist Small molecule therapeutic designed for treatment of neurological diseases such as multiple sclerosisEdinburgh, UK, 14 January 2025: Pheno Therapeutics Limited., a biotechnology company focused on the disco...

    CN BIO logo
    14 January 2025

    CN Bio signs strategic partnership with Primetech Corporation to establish distribution channel for OOC solutions in Japan

    Agreement establishes direct distribution channel for customers in Japan, providing local support and expertise Partnership solidifies CN Bio’s presence in Asian markets and supports ongoing global expansionCambridge, UK, 14 January 2025: CN Bio, a leading provider of Organ-on-a-ch...

    Sable&Hawkes deliver a complete NHS environment design service from creative theme to creative design, production, supplier and installation management.
    14 January 2025

    Sable&Hawkes appointed for major new environment design project with Gt Ormond Street Hospital

    Great Ormond Street Hospital (GOSH) is a world-renowned international centre of excellence in child healthcare. Cambridge-based design and communication agency Sable&Hawkes was commissioned by GOSH to work with them on a major new environment and signage project. ...

    GUARD
    13 January 2025

    Guardtech’s ‘full life cycle’ approach offering cleanroom facility protection from start to finish

    Suffolk-based contamination control specialists’ holistic cleanroom installation programmes boast comprehensive maintenance and decontamination aftercare packages. ...

    Gabe Longoria, CCO, 4BaseBio
    9 January 2025

    4basebio appoints Gabe Longoria as Chief Commercial Officer

    Cambridge, UK, 09 January 2025 - 4basebio PLC (AIM: 4BB) (“4basebio”), a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced the appointment of Gabe Longoria as Chief Commercial Officer o...

    Digital Health Award, Dr Chris Macdonald, Virtual Reality Public Speaking
    9 January 2025

    Cambridge VR project wins international award

    Cambridge lab wins Digital Health Award for cutting-edge virtual reality platform that eliminates the fear of public speaking. ...

    Bio-Rad and Genoscopy
    8 January 2025

    Geneoscopy closes $105M in Series C funding round to power next-generation of gastrointestinal diagnostic tests

    Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease ...

    Anaesthetist using video-enabled stylet with display attached to laryngoscope to intubate patient for surgery
    8 January 2025

    42 Technology launches low-cost, video stylet at CES 2025

    42 Technology (42T) has launched an innovative, video-capable medical device at CES 2025 this week designed to improve the speed and safety of patient intubation during surgery and emergency care. ...

    Eight Signs That You Employees Are Not Resilient: Number One - They struggle to handle challenges effectively.
    8 January 2025

    Eight signs that your employees are not resilient: part 1

    A report from Aon entitled "The Rising Resilience Study" stated that in 2019 only 30% of employees felt resilient. That means that before the Pandemic, 70% of employees did not feel resilient. Lack of resilience amongst the workforce can result in huge costs and poor staff retention. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 103
    • Page 104
    • Current page 105
    • Page 106
    • Page 107
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS